Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about FMC Corporation
FMC Corporation News
FMC Corporation Quantitative Score
About FMC Corporation
FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that include insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. FMC Corporation was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.
FMC Corporation Earnings & Revenue
FMC Corporation Financials
Table Compare
Compare FMC metrics with: | |||
|---|---|---|---|
Earnings & Growth | FMC | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | FMC | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | FMC | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | FMC | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
FMC Corporation Income
FMC Corporation Balance Sheet
FMC Corporation Cash Flow
FMC Corporation Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Neutral |
| Return on Equity | Buy |
| Return on Assets | Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
FMC Corporation Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 2.3200 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2024-10-17 | 0.58 | Quarterly |
| 2024-07-18 | 0.58 | Quarterly |
| 2024-04-18 | 0.58 | Quarterly |
| 2024-01-18 | 0.58 | Quarterly |
| 2023-10-19 | 0.58 | Quarterly |
FMC Corporation Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
FMC Corporation Executives
| Name | Role |
|---|---|
| Mr. Andrew D. Sandifer | Executive Vice President & Chief Financial Officer |
| Mr. Ronaldo Pereira | President |
| Mr. Michael Finian Reilly | Executive Vice President, General Counsel, Chief Compliance Officer & Secretary |
| Ms. Jacqueline D. Scanlan | Executive Vice President & Chief HR Officer |
| Dr. Pierre R. Brondeau Ph.D. | Chief Executive Officer & Non-Executive Chairman of the Board |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Andrew D. Sandifer | Executive Vice President & Chief Financial Officer | Male | 1970 | 1.24M |
| Mr. Ronaldo Pereira | President | Male | 1973 | 865.73K |
| Mr. Michael Finian Reilly | Executive Vice President, General Counsel, Chief Compliance Officer & Secretary | Male | 1964 | 801.36K |
| Ms. Jacqueline D. Scanlan | Executive Vice President & Chief HR Officer | Female | 1974 | 598.87K |
| Dr. Pierre R. Brondeau Ph.D. | Chief Executive Officer & Non-Executive Chairman of the Board | 1958 | 250K |
FMC Corporation Insider Trades
| Date | 11 Nov |
| Name | Scanlan Jacqueline |
| Role | Executive VP & Chief HRO |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 4529 |
| Date | 17 Oct |
| Name | Verduin Patricia |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 11 |
| Date | 17 Oct |
| Name | Raines John Mitchell |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 12 |
| Date | 17 Oct |
| Name | Pallash Robert C |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 406 |
| Date | 17 Oct |
| Name | Oevrum Margareth |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 127 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 11 Nov | Scanlan Jacqueline | Executive VP & Chief HRO | Disposed | S-Sale | 4529 |
| 17 Oct | Verduin Patricia | Director | Acquired | A-Award | 11 |
| 17 Oct | Raines John Mitchell | Director | Acquired | A-Award | 12 |
| 17 Oct | Pallash Robert C | Director | Acquired | A-Award | 406 |
| 17 Oct | Oevrum Margareth | Director | Acquired | A-Award | 127 |